NSX - By Stock
|
VTL |
Ann:Quarterly Report (Price Sensitive)
|
|
NSX News
|
0 |
85 |
0 |
22/04/24 |
22/04/24 |
NSX - By Stock
|
Thread
|
0
|
85
|
0
|
|
NSX - By Stock
|
VTL |
Ann:Director's Declaration for Richard Estalella (Price Sensitive)
|
|
NSX News
|
0 |
126 |
0 |
23/02/24 |
23/02/24 |
NSX - By Stock
|
Thread
|
0
|
126
|
0
|
|
NSX - By Stock
|
VTL |
Ann:VTL - New Partnership (Price Sensitive)
|
|
NSX News
|
0 |
123 |
0 |
14/02/24 |
14/02/24 |
NSX - By Stock
|
Thread
|
0
|
123
|
0
|
|
NSX - By Stock
|
VTL |
Ann:Board Changes
|
|
NSX News
|
0 |
115 |
0 |
14/02/24 |
14/02/24 |
NSX - By Stock
|
Thread
|
0
|
115
|
0
|
|
NSX - By Stock
|
VTL |
Ann:Initial Director's Notice
|
|
NSX News
|
0 |
133 |
0 |
14/02/24 |
14/02/24 |
NSX - By Stock
|
Thread
|
0
|
133
|
0
|
|
NSX - By Stock
|
VTL |
Ann:Final Director's Notice
|
|
NSX News
|
0 |
143 |
0 |
14/02/24 |
14/02/24 |
NSX - By Stock
|
Thread
|
0
|
143
|
0
|
|
NSX - By Stock
|
VTL |
Ann:Half Year Report (Price Sensitive)
|
|
NSX News
|
0 |
136 |
0 |
08/02/24 |
08/02/24 |
NSX - By Stock
|
Thread
|
0
|
136
|
0
|
|
NSX - By Stock
|
VTL |
Ann:Dec '23 Quarterly Report (Price Sensitive)
|
|
NSX News
|
0 |
143 |
0 |
23/01/24 |
23/01/24 |
NSX - By Stock
|
Thread
|
0
|
143
|
0
|
|
NSX - By Stock
|
VTL |
Ann:HREC Approval for Phase II Clinical Study (Price Sensitive)
|
|
NSX News
|
0 |
184 |
0 |
11/01/24 |
11/01/24 |
NSX - By Stock
|
Thread
|
0
|
184
|
0
|
|
NSX - By Stock
|
VTL |
Ann:Results of 2023 AGM
|
|
NSX News
|
0 |
220 |
0 |
04/12/23 |
04/12/23 |
NSX - By Stock
|
Thread
|
0
|
220
|
0
|
|
NSX - By Stock
|
VTL |
Ann:2022023 Annual General Meeting
|
|
NSX News
|
0 |
247 |
0 |
25/10/23 |
25/10/23 |
NSX - By Stock
|
Thread
|
0
|
247
|
0
|
|
NSX - By Stock
|
VTL |
Ann:Quarterly Report (Price Sensitive)
|
|
NSX News
|
0 |
287 |
0 |
25/10/23 |
25/10/23 |
NSX - By Stock
|
Thread
|
0
|
287
|
0
|
|
NSX - By Stock
|
VTL |
Ann:Nominated Adviser's Declaration - Dash Corporate Lawyers Pty Ltd
|
|
NSX News
|
0 |
290 |
0 |
02/10/23 |
02/10/23 |
NSX - By Stock
|
Thread
|
0
|
290
|
0
|
|
NSX - By Stock
|
VTL |
Ann:2023 Annual Report
|
|
NSX News
|
0 |
286 |
0 |
07/09/23 |
07/09/23 |
NSX - By Stock
|
Thread
|
0
|
286
|
0
|
|
NSX - By Stock
|
VTL |
Ann:VTL commences divestment of Invictus BioPharma Pty Ltd
|
|
NSX News
|
0 |
314 |
0 |
29/08/23 |
29/08/23 |
NSX - By Stock
|
Thread
|
0
|
314
|
0
|
|
NSX - By Stock
|
VTL |
Ann:Annual Nominated Adviser Statement for 2023 - 2024
|
|
NSX News
|
0 |
346 |
0 |
11/08/23 |
11/08/23 |
NSX - By Stock
|
Thread
|
0
|
346
|
0
|
|
NSX - By Stock
|
VTL |
Ann:Quarterly Report (Price Sensitive)
|
|
NSX News
|
0 |
273 |
0 |
28/07/23 |
28/07/23 |
NSX - By Stock
|
Thread
|
0
|
273
|
0
|
|
NSX - By Stock
|
VTL |
Ann:New R & D Loan (Price Sensitive)
|
|
NSX News
|
0 |
371 |
0 |
29/06/23 |
29/06/23 |
NSX - By Stock
|
Thread
|
0
|
371
|
0
|
|
NSX - By Stock
|
VTL |
Ann:Extension of Sunset Date
|
|
NSX News
|
0 |
258 |
0 |
26/06/23 |
26/06/23 |
NSX - By Stock
|
Thread
|
0
|
258
|
0
|
|
NSX - By Stock
|
VTL |
Ann:Change of Registered Address
|
|
NSX News
|
0 |
349 |
0 |
26/06/23 |
26/06/23 |
NSX - By Stock
|
Thread
|
0
|
349
|
0
|
|
|
NSX - By Stock
|
VTL |
Re:
Ann:Quarterly Report (Price Sensitive)
|
|
Jamesie05
|
1 |
706 |
0 |
05/06/23 |
05/06/23 |
NSX - By Stock
|
Thread
|
1
|
706
|
0
|
|
NSX - By Stock
|
VTL |
Ann:Quarterly Report (Price Sensitive)
|
|
NSX News
|
1 |
706 |
0 |
19/04/23 |
19/04/23 |
NSX - By Stock
|
Thread
|
1
|
706
|
0
|
|
NSX - By Stock
|
VTL |
Ann:Extension of Sunset Date
|
|
NSX News
|
0 |
489 |
0 |
03/04/23 |
03/04/23 |
NSX - By Stock
|
Thread
|
0
|
489
|
0
|
|
NSX - By Stock
|
VTL |
Ann:Interim Report (Price Sensitive)
|
|
NSX News
|
0 |
537 |
0 |
16/02/23 |
16/02/23 |
NSX - By Stock
|
Thread
|
0
|
537
|
0
|
|
NSX - By Stock
|
VTL |
Ann:Quarterly Update
|
|
NSX News
|
0 |
489 |
0 |
31/01/23 |
31/01/23 |
NSX - By Stock
|
Thread
|
0
|
489
|
0
|
|
NSX - By Stock
|
VTL |
Ann:Quarterly Report - 31 December 2022 (Price Sensitive)
|
|
NSX News
|
0 |
420 |
0 |
31/01/23 |
31/01/23 |
NSX - By Stock
|
Thread
|
0
|
420
|
0
|
|
NSX - By Stock
|
VTL |
Ann:Update on sale of IVB (Price Sensitive)
|
|
NSX News
|
0 |
533 |
0 |
21/12/22 |
21/12/22 |
NSX - By Stock
|
Thread
|
0
|
533
|
0
|
|
NSX - By Stock
|
VTL |
Ann:Company Update
|
|
NSX News
|
0 |
555 |
0 |
21/12/22 |
21/12/22 |
NSX - By Stock
|
Thread
|
0
|
555
|
0
|
|
NSX - By Stock
|
VTL |
Ann:Update on NAFLD/NASH Phase II Clinical Study
|
|
NSX News
|
0 |
535 |
0 |
19/12/22 |
19/12/22 |
NSX - By Stock
|
Thread
|
0
|
535
|
0
|
|
NSX - By Stock
|
VTL |
Ann:2022 AGM Results
|
|
NSX News
|
0 |
516 |
0 |
30/11/22 |
30/11/22 |
NSX - By Stock
|
Thread
|
0
|
516
|
0
|
|
NSX - By Stock
|
VTL |
Ann:Extension of Sunset Date (Price Sensitive)
|
|
NSX News
|
0 |
450 |
0 |
29/11/22 |
29/11/22 |
NSX - By Stock
|
Thread
|
0
|
450
|
0
|
|
NSX - By Stock
|
VTL |
Ann:Update on sale of IVB (Price Sensitive)
|
|
NSX News
|
0 |
406 |
0 |
25/10/22 |
25/10/22 |
NSX - By Stock
|
Thread
|
0
|
406
|
0
|
|
NSX - By Stock
|
VTL |
Ann:2022 Annual General Meeting
|
|
NSX News
|
0 |
269 |
0 |
25/10/22 |
25/10/22 |
NSX - By Stock
|
Thread
|
0
|
269
|
0
|
|
NSX - By Stock
|
VTL |
Ann:2022 AGM Proxy Form
|
|
NSX News
|
0 |
314 |
0 |
25/10/22 |
25/10/22 |
NSX - By Stock
|
Thread
|
0
|
314
|
0
|
|
NSX - By Stock
|
VTL |
Ann:Sept 2022 Quarterly Report (Price Sensitive)
|
|
NSX News
|
0 |
359 |
0 |
19/10/22 |
19/10/22 |
NSX - By Stock
|
Thread
|
0
|
359
|
0
|
|
NSX - By Stock
|
VTL |
Ann:Sept 2022 Quarterly Update (Price Sensitive)
|
|
NSX News
|
0 |
439 |
0 |
19/10/22 |
19/10/22 |
NSX - By Stock
|
Thread
|
0
|
439
|
0
|
|
NSX - By Stock
|
VTL |
Ann:Extension of Convertible Note Facility Term (Price Sensitive)
|
|
NSX News
|
0 |
416 |
0 |
14/10/22 |
14/10/22 |
NSX - By Stock
|
Thread
|
0
|
416
|
0
|
|
NSX - By Stock
|
VTL |
Ann:R & D Facility Agreement with Fundsquire Pty Ltd (Price Sensitive)
|
|
NSX News
|
0 |
408 |
0 |
13/10/22 |
13/10/22 |
NSX - By Stock
|
Thread
|
0
|
408
|
0
|
|
NSX - By Stock
|
VTL |
Ann:NAFLD/NASH Phase II Clinical Study (Price Sensitive)
|
|
NSX News
|
0 |
390 |
0 |
05/10/22 |
05/10/22 |
NSX - By Stock
|
Thread
|
0
|
390
|
0
|
|
NSX - By Stock
|
VTL |
Ann:Ethics approval received for US Clinical Study (Price Sensitive)
|
|
NSX News
|
0 |
424 |
0 |
26/09/22 |
26/09/22 |
NSX - By Stock
|
Thread
|
0
|
424
|
0
|
|
NSX - By Stock
|
VTL |
Re:
Ann:NAFLD/NASH PhaseII Clinical Study Recruits 1st Patient (Price Sensitive)
|
|
Jamesie05
|
1 |
809 |
0 |
21/09/22 |
21/09/22 |
NSX - By Stock
|
Thread
|
1
|
809
|
0
|
|
NSX - By Stock
|
VTL |
Ann:NAFLD/NASH PhaseII Clinical Study Recruits 1st Patient (Price Sensitive)
|
|
NSX News
|
1 |
809 |
0 |
14/09/22 |
14/09/22 |
NSX - By Stock
|
Thread
|
1
|
809
|
0
|
|
NSX - By Stock
|
VTL |
Re:
Ann:Updated Invictus BioPharma Group sale date (Price Sensitive)
|
|
Jamesie05
|
1 |
632 |
0 |
09/09/22 |
09/09/22 |
NSX - By Stock
|
Thread
|
1
|
632
|
0
|
|
NSX - By Stock
|
VTL |
Ann:Updated Invictus BioPharma Group sale date (Price Sensitive)
|
|
NSX News
|
1 |
632 |
0 |
08/09/22 |
08/09/22 |
NSX - By Stock
|
Thread
|
1
|
632
|
0
|
|
NSX - By Stock
|
VTL |
Ann:Annual Nominated Adviser Statement for 2022 - 2023
|
|
NSX News
|
0 |
476 |
0 |
05/09/22 |
05/09/22 |
NSX - By Stock
|
Thread
|
0
|
476
|
0
|
|
NSX - By Stock
|
VTL |
Ann:2022 Annual Report (Price Sensitive)
|
|
NSX News
|
0 |
771 |
0 |
10/08/22 |
10/08/22 |
NSX - By Stock
|
Thread
|
0
|
771
|
0
|
|
NSX - By Stock
|
VTL |
Ann:June 2022 Quarterly Update
|
|
NSX News
|
0 |
319 |
0 |
29/07/22 |
29/07/22 |
NSX - By Stock
|
Thread
|
0
|
319
|
0
|
|
NSX - By Stock
|
VTL |
Ann:June 2022 Quarterly Report (Price Sensitive)
|
|
NSX News
|
0 |
314 |
0 |
29/07/22 |
29/07/22 |
NSX - By Stock
|
Thread
|
0
|
314
|
0
|
|
NSX - By Stock
|
VTL |
Ann:Clinical Study begins recruitment of patients
|
|
NSX News
|
0 |
306 |
0 |
05/07/22 |
05/07/22 |
NSX - By Stock
|
Thread
|
0
|
306
|
0
|
|